257 related articles for article (PubMed ID: 23028625)
1. Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.
Schmidt SK; Siepmann S; Kuhlmann K; Meyer HE; Metzger S; Pudelko S; Leineweber M; Däubener W
PLoS One; 2012; 7(9):e44797. PubMed ID: 23028625
[TBL] [Abstract][Full Text] [Related]
2. Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions.
Schmidt SK; Ebel S; Keil E; Woite C; Ernst JF; Benzin AE; Rupp J; Däubener W
PLoS One; 2013; 8(5):e63301. PubMed ID: 23675474
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
[TBL] [Abstract][Full Text] [Related]
5. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
Qian F; Villella J; Wallace PK; Mhawech-Fauceglia P; Tario JD; Andrews C; Matsuzaki J; Valmori D; Ayyoub M; Frederick PJ; Beck A; Liao J; Cheney R; Moysich K; Lele S; Shrikant P; Old LJ; Odunsi K
Cancer Res; 2009 Jul; 69(13):5498-504. PubMed ID: 19491279
[TBL] [Abstract][Full Text] [Related]
7. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects.
Müller A; Heseler K; Schmidt SK; Spekker K; Mackenzie CR; Däubener W
J Cell Mol Med; 2009 Jun; 13(6):1125-35. PubMed ID: 19602041
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of 1-methyltryptophan isomers in renal ischemia-reperfusion injury is not exclusively dependent on indolamine 2,3-dioxygenase inhibition.
Čepcová D; Kema IP; Sandovici M; Deelman LE; Šišková K; Klimas J; Vavrinec P; Vavrincová-Yaghi D
Biomed Pharmacother; 2021 Mar; 135():111180. PubMed ID: 33433354
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.
Heseler K; Spekker K; Schmidt SK; MacKenzie CR; Däubener W
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):273-81. PubMed ID: 18205804
[TBL] [Abstract][Full Text] [Related]
10. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
Opitz CA; Litzenburger UM; Opitz U; Sahm F; Ochs K; Lutz C; Wick W; Platten M
PLoS One; 2011; 6(5):e19823. PubMed ID: 21625531
[TBL] [Abstract][Full Text] [Related]
11. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
Liu X; Zhou W; Zhang X; Ding Y; Du Q; Hu R
Int J Cancer; 2018 Sep; 143(6):1516-1529. PubMed ID: 29607498
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
Hou DY; Muller AJ; Sharma MD; DuHadaway J; Banerjee T; Johnson M; Mellor AL; Prendergast GC; Munn DH
Cancer Res; 2007 Jan; 67(2):792-801. PubMed ID: 17234791
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
[No Abstract] [Full Text] [Related]
15. The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes.
Eleftheriadis T; Pissas G; Karioti A; Antoniadi G; Liakopoulos V; Dafopoulou K; Pournaras S; Koukoulis G; Stefanidis I
Immunol Invest; 2012; 41(5):507-20. PubMed ID: 22594922
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase.
Schmidt SK; Müller A; Heseler K; Woite C; Spekker K; MacKenzie CR; Däubener W
Eur J Immunol; 2009 Oct; 39(10):2755-64. PubMed ID: 19637229
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
18. 1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function.
Ma H; Qin Q; Mi J; Feng Q
BMC Pharmacol Toxicol; 2020 Sep; 21(1):67. PubMed ID: 32912307
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase: is it an immune suppressor?
Soliman H; Mediavilla-Varela M; Antonia S
Cancer J; 2010; 16(4):354-9. PubMed ID: 20693847
[TBL] [Abstract][Full Text] [Related]
20. Human renal tubular epithelial cells suppress alloreactive T cell proliferation.
Demmers MW; Korevaar SS; Roemeling-van Rhijn M; van den Bosch TP; Hoogduijn MJ; Betjes MG; Weimar W; Baan CC; Rowshani AT
Clin Exp Immunol; 2015 Mar; 179(3):509-19. PubMed ID: 25310899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
